DENTSPLY SIRONA’s (XRAY) Hold Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report sent to investors on Friday,Benzinga reports.

Several other analysts also recently commented on XRAY. Wall Street Zen downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Wells Fargo & Company reduced their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a report on Friday, August 8th. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, August 8th. UBS Group cut their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Finally, Stifel Nicolaus cut their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $18.64.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $12.50 on Friday. The company has a market capitalization of $2.49 billion, a price-to-earnings ratio of -2.64, a PEG ratio of 0.77 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The company has a 50-day simple moving average of $14.14 and a 200 day simple moving average of $14.81. DENTSPLY SIRONA has a 52 week low of $12.14 and a 52 week high of $27.44.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. DENTSPLY SIRONA’s revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, sell-side analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a $0.16 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.1%. DENTSPLY SIRONA’s payout ratio is presently -13.50%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently made changes to their positions in the company. Envestnet Asset Management Inc. raised its position in shares of DENTSPLY SIRONA by 9.0% in the 1st quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock valued at $7,391,000 after buying an additional 40,936 shares in the last quarter. Brown Advisory Inc. acquired a new position in DENTSPLY SIRONA during the 1st quarter worth approximately $679,000. Dynamic Technology Lab Private Ltd acquired a new position in DENTSPLY SIRONA during the 1st quarter worth approximately $366,000. Krilogy Financial LLC acquired a new position in DENTSPLY SIRONA during the 2nd quarter worth approximately $336,000. Finally, Wealth Enhancement Advisory Services LLC increased its position in DENTSPLY SIRONA by 39.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier’s stock worth $805,000 after purchasing an additional 15,117 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.